title: Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects.
abstract: In vascular smooth muscle cells, NO stimulates the synthesis of cGMP by soluble guanylate cyclase (sGC), a heterodimer composed of alpha(1) and beta(1) subunits. NO/cGMP signal transduction affects multiple cell functions that contribute to neointima formation after vascular injury. Balloon-induced vascular injury was found to decrease sGC subunit expression and enzyme activity in rat carotid arteries. The effect of restoring sGC enzyme activity on neointima formation was investigated using recombinant adenoviruses specifying sGC alpha(1) and beta(1) subunits (Adalpha1 and Adbeta1). Coinfection of cultured rat aortic smooth muscle cells with Adalpha1 and Adbeta1 increased NO-stimulated intracellular cGMP levels 60-fold and decreased DNA synthesis and migration by 16% and 48%, respectively. Immunoreactivity for alpha(1) and beta(1) subunits colocalized in carotid arteries infected with Adalpha1 and Adbeta1. Molsidomine-stimulated carotid tissue cGMP levels were greater after coinfection with Adalpha1 and Adbeta1 than after infection with a control virus, AdRR5 (0.53+/-0.09 pmol/mg protein, mean+/-SEM, versus 0.23+/-0.09, P<0.05). Mean intima/media ratio, 2 weeks after balloon injury and twice-daily administration of 5 mg/kg molsidomine, was less in rats coinfected with Adalpha1 and Adss1 than in rats infected with AdRR5 or in uninfected rats (0.36+/-0.11 versus 0. 81+/-0.13 and 0.75+/-0.25, respectively, P<0.05). Thus, Adalpha1 and Adbeta1 gene transfer to balloon-injured rat carotid arteries increases NO responsiveness and attenuates neointima formation via a direct antiproliferative and antimigratory effect on vascular smooth muscle cells.
authors.affiliation: Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, University Hospital Gasthuisberg, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: Sinnaeve
authors.forename: J D
authors.initials: JD
authors.lastname: Chiche
authors.forename: Z
authors.initials: Z
authors.lastname: Nong
authors.forename: O
authors.initials: O
authors.lastname: Varenne
authors.forename: N
authors.initials: N
authors.lastname: Van Pelt
authors.forename: H
authors.initials: H
authors.lastname: Gillijns
authors.forename: D
authors.initials: D
authors.lastname: Collen
authors.forename: K D
authors.initials: KD
authors.lastname: Bloch
authors.forename: S
authors.initials: S
authors.lastname: Janssens
mesh_terms: D000800:Angioplasty, Balloon / Q000009:adverse effects; D000818:Animals; D002339:Carotid Arteries / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D020212:Carotid Artery Injuries / Q000209:etiology / Q000235:genetics / Q000503:physiopathology*; D002455:Cell Division / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000378:metabolism; D018014:Gene Transfer Techniques; D006162:Guanylate Cyclase / Q000235:genetics / Q000378:metabolism*; D008981:Molsidomine / Q000494:pharmacology; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology*; D020030:Nitric Oxide Donors / Q000494:pharmacology; D051381:Rats; D012995:Solubility; D017539:Tunica Intima / Q000187:drug effects / Q000503:physiopathology*
chemical_list: D020030:Nitric Oxide Donors; D009569:Nitric Oxide; D008981:Molsidomine; D006162:Guanylate Cyclase; D006152:Cyclic GMP